Statin can reduce the risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis

aDepartment of Gastroenterology, the Second Xiangya Hospital of Central South University

bResearch Center of Digestive Disease, Central South University, Changsha, China

Received 28 October 2022 Accepted 3 January 2023.

Correspondence to Yongjun Wang, MD, Department of Gastroenterology, the Second Xiangya Hospital of Central South University, ChangshaHunan 410011, China, Tel: +86 13677486038; e-mail: [email protected]

留言 (0)

沒有登入
gif